IVI Highlighted in Article on Value Assessment in Oncology Treatments
In this month’s Drug Topics, correspondent Kathleen Gannon Longo speaks with Jeremy Schafer about the potentially tremendous impact that value assessments will have on future patient reimbursement decisions. Focusing on Oncology treatment, Schafer describes some of the existing value frameworks in play as well as referencing the work being done by the IVI to employ […]
Measuring Value: Jason Shafrin in The Journal of Healthcare Contracting
IVI Director of Research, Jason Shafrin, discusses the need for and mission of the IVI, as well as the keys to its success in the latest edition of The Journal of Healthcare Contracting. “If we find a research topic that life sciences, payers, providers are all behind and agree on — that’s a pretty powerful thing,” […]
New Patient-Centered Tool Could Help Measure Value in Health Care
IVI Director of Scientific Communications, Mark Linthicum, talked to Managed Healthcare Executive about how the Open-Source Value Project (OSVP) is going to change the way we approach value assessment and ultimately measure value in health care treatments and services. Read the full article here.
An Open-Source Approach Will Drive Healthcare Value Assessment 2.0
Measuring value in healthcare, which frequently takes the perspective of a single payer managing population health and costs, needs to evolve to include diverse perspectives and provide relevant and actionable information on value to healthcare decision makers, according to a new article written by IVI’s Mark Linthicum, Jennifer Bright and Jason Shafrin and published in […]
IVI Fosters a Middle Ground for Value Assessment Discussions
In an article published on AJMC.com, IVI’sJennifer Bright and Mark Linthicum argue value assessment stakeholders need to have transparent discussions about value assessment and understand what value means from other points of view. Read the full article here.
Bright at Xtelligent Media Panel: Value Assessment Platform Must Go Beyond Population Averages
IVI’s Jennifer Bright participated in a panel of discussion at the recent Value-Based Summit, organized by Xtelligent media. Bright’s panel, “Healthcare Quality Measurement,” examined how healthcare stakeholders are looking at insights derived from measurement initiatives to support value-based care. Read more here.
Precision Benefit Design: How should the arrival of precision medicine affect health plan benefit design?
Advances in precision medicine offer the promise of tremendous gains in patient health over the coming decades. Headlines in the popular press as well as discussions at academic conferences tout the potential benefits of precision medicine, while at the same time critiquing the nascent but growing evidence base and the high cost of treatment. One […]
Is One Answer Good Enough for All? Defining Value in Healthcare
While it makes sense for value assessment to be woven into healthcare decision making, relying on a single method to measure value and using this metric to restrict treatment access is shortsighted. IVI’s Jennifer Bright and Mark Linthicum address this concern in a recent article for the American Journal of Managed Care (AJMC). Read the […]
IVI Provides Insight into CVS Health’s Decision to Include Cost-per-QALY Analyses from ICER into Formulary Decision-Making
CVS Health’s pharmacy benefit management (PBM) division, CVS Caremark, recently announced their decision to rely exclusively on the analyses of the Institute for Clinical and Economic (ICER) in a new drug management program. IVI’s Director of Scientific Communications, Mark Linthicum, responds to this story in MedCity stating, “The neat ‘answer’ regarding the value of treatment […]
Why Quality Measures Must Reflect Patient Values, Care Experience
There isn’t an easy answer to assessing value in healthcare, but IVI is working to tackle the problems through considerable research and experimentation by developing an open-source value platform that considers no only clinical factors, but patient perspectives as well. In a recent interview with PatientEngagementHIT.com, IVI’s Jennifer Bright (Executive Director) and Mark Linthicum (Director […]